Bio-Techne Corporation Stock Price and Value Analysis

Should you buy Bio-Techne Corporation stock? (NasdaqGS:TECH). Let's see how it does in our automated value investing analysis system.

  • This company has wild ups and downs.
  • This company has a low dividend yield.
  • This company is making money at a modest rate.
  • This company is less known than others.
  • This stock looks overpriced.

TECH Free Cash Flow Trend

Based on historical returns, we believe that Bio-Techne Corporation can grow its free cash at a rate of about 4%. That's positive!

Free Cash Flow trendline for TECH
Free Cash Flow trendline for Bio-Techne Corporation

Inside the TECH Numbers

TECH Price
(Bio-Techne Corporation stock price per share)
[?] TECH Fair Price
(based on intrinsic value)
[?] TECH Safety Price (based on a variable margin of safety) $34.62
[?] PE Ratio versus Sector 137% higher than other Healthcare stocks
[?] PE Ratio versus Industry 16% lower than other Biotechnology stocks
[?] Cash Yield 3.51%
[?] Free Cash Flow Jitter 37%
[?] Dividend Yield 1%

Is Bio-Techne Corporation Stock on Sale?

We believe that Bio-Techne Corporation may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Bio-Techne Corporation looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy TECH Stock?

Does Bio-Techne Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.